In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
Novartis teams up with Lindy Biosciences to improve biologic delivery – Pharmaceutical Technology
Novartis will gain exclusive access to the Lindy’s flagship microglassification technology. Credit: skynesher via Getty Images. Novartis has set its sights on the North Carolina
August 29, 2024